Search research articles
Contact Us
Filters
Showing results (21-30 of 180) with videos related to
Page
of 18
Sort By:
Fertility and Sterility
|
March 21, 2008
Does the fimbria have an embryologic origin distinct from that of the rest of the fallopian tube?
Leslie A Garrett, Sara O Vargas, Ronny Drapkin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 15, 2014
Combined therapy with thrombospondin-1 type I repeats (3TSR) and chemotherapy induces regression and significantly improves survival in a preclinical model of advanced stage epithelial ovarian cancer
Samantha Russell, Mark Duquette, Joyce Liu, et al.
Cancers
|
November 21, 2019
Imaging Collagen Alterations in STICs and High Grade Ovarian Cancers in the Fallopian Tubes by Second Harmonic Generation Microscopy
Eric C Rentchler, Kristal L Gant, Ronny Drapkin, et al.
Clinical Medicine & Research
|
April 26, 2007
Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer
Christopher P Crum, Ronny Drapkin, David Kindelberger, et al.
The American Journal of Surgical Pathology
|
December 6, 2012
Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity
Brooke E Howitt, Marisa R Nucci, Ronny Drapkin, et al.
Histopathology
|
March 11, 2015
GATA3 expression in gestational trophoblastic tissues and tumours
Jelena Mirkovic, Kevin Elias, Ronny Drapkin, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
April 7, 2004
Association of BRCA1 with the inactive X chromosome and XIST RNA
Shridar Ganesan, Daniel P Silver, Ronny Drapkin, et al.
Cell Death & Disease
|
April 26, 2020
CtBP determines ovarian cancer cell fate through repression of death receptors
Boxiao Ding, Fang Yuan, Priyadarshan K Damle, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
June 27, 2008
Adenofibroma of the fimbria: a common entity that is indistinguishable from ovarian adenofibroma
Veerle Bossuyt, Fabiola Medeiros, Ronny Drapkin, et al.
Science Signaling
|
November 19, 2024
Repurposing colforsin daropate to treat MYC-driven high-grade serous ovarian carcinomas
Matthew J Knarr, Jamie Moon, Priyanka Rawat, et al.
Page
of 18
Search research articles
Search
Showing results (21-30 of 180) with videos related to
Sort By:
Page
of 18
Fertility and Sterility
|
March 21, 2008
Does the fimbria have an embryologic origin distinct from that of the rest of the fallopian tube?
Leslie A Garrett, Sara O Vargas, Ronny Drapkin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 15, 2014
Combined therapy with thrombospondin-1 type I repeats (3TSR) and chemotherapy induces regression and significantly improves survival in a preclinical model of advanced stage epithelial ovarian cancer
Samantha Russell, Mark Duquette, Joyce Liu, et al.
Cancers
|
November 21, 2019
Imaging Collagen Alterations in STICs and High Grade Ovarian Cancers in the Fallopian Tubes by Second Harmonic Generation Microscopy
Eric C Rentchler, Kristal L Gant, Ronny Drapkin, et al.
Clinical Medicine & Research
|
April 26, 2007
Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer
Christopher P Crum, Ronny Drapkin, David Kindelberger, et al.
The American Journal of Surgical Pathology
|
December 6, 2012
Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity
Brooke E Howitt, Marisa R Nucci, Ronny Drapkin, et al.
Histopathology
|
March 11, 2015
GATA3 expression in gestational trophoblastic tissues and tumours
Jelena Mirkovic, Kevin Elias, Ronny Drapkin, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
April 7, 2004
Association of BRCA1 with the inactive X chromosome and XIST RNA
Shridar Ganesan, Daniel P Silver, Ronny Drapkin, et al.
Cell Death & Disease
|
April 26, 2020
CtBP determines ovarian cancer cell fate through repression of death receptors
Boxiao Ding, Fang Yuan, Priyadarshan K Damle, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
June 27, 2008
Adenofibroma of the fimbria: a common entity that is indistinguishable from ovarian adenofibroma
Veerle Bossuyt, Fabiola Medeiros, Ronny Drapkin, et al.
Science Signaling
|
November 19, 2024
Repurposing colforsin daropate to treat MYC-driven high-grade serous ovarian carcinomas
Matthew J Knarr, Jamie Moon, Priyanka Rawat, et al.
Page
of 18